µÚËľüÒ½´óѧһ¾Å¾Å¶þÄê¹¥¶Á²©Ê¿Ñ§Î»Ñо¿ÉúÈëѧÊÔÌâ ѧ¿Æרҵ£º i#I+
|
%JJ
S^)
´«È¾²¡Ñ§ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ |1d;0*HIgX
; z_ZZ(W
Ò». Ãû´Ê½âÊÍ(ÿÌâ4·Ö,¹²32·Ö) q'kZ3G
/]=dPb%
1. ICAM-1 &
[)1LRt_
N>z<v\`
2. interleukin 12(IL-12) \VL[,z=q.
5m,{?M`
3. tumor infiltrating lymphocyte 2mS3gk
}V.Wp6"S
4. TCR/CD3 complex b&.j>=
9z9z
:PU
5. hematopoietin receptor family Q9X7-\n
FY%v \`@1*
6. individual idiotype(IdI) +5pK[%k
V>}@--$c-r
7. integrin F"O{eK0T
#W#GI"K
8. colony-stimulatory factor (CSF) \tFg10
\-kX-Tq
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© 2XJn3wPi
%=x|.e@J
1. ÃâÒßÇòµ°°×ÖØÁ´µÄ»ùÒòÈçºÎ½øÐÐÀà±ðת»»(class switching )? 0'!v-`.
Z5juyzj
2. ¼òÊöɱÉËÐÔTϸ°û(Tc)ɱÉ˲¡¶¾¸ÐȾ°Ðϸ°ûµÄ»úÀí¡£ }^uUw&
dj*%^cI
3. ÉúÎïÓ¦´ðµ÷½Ú¼Á( biological response modifier,BRM)Ö÷ÒªÓÐÄļ¸Àà?¼òÒª½éÉÜÔÚ´«È¾ÐÔ¼²²¡·ÀÖÎÖеÄ×÷Óᣠ;\7TQ9z
y'?|#%D
4. ¼òÊö¿¹ÔÌá³Êϸ°û(APC)Ó븨ÖúÐÔTϸ°û(Th)Ï໥×÷ÓõĹØϵ¡£ 9"_JiX~3
z'a#lA.$}
Èý. ÎÊ´ðÌâ(ÿÌâ18·Ö,¹²36·Ö) 96
;17h$
`j*&F8}
1. ÊÔÊö¸ÉÈÅËصķÖÀ༰ÆäÉúÎïѧ×÷ÓÃÌص㡣Ö÷Òª¿ÉÒÔÖÎÁÆÄÄЩ´«È¾ÐÔ¼²²¡?¼òÊö¸ÉÈÅËؼì²âµÄ·½·¨ºÍÔÀí¡£ _[8xq:G
iorKS+w"
2. ºÎΪ»ùÒò¹¤³Ì¿¹Ìå?Ä¿Ç°¹úÄÚÍâÔÚ»ùÒò¹¤³Ì¿¹ÌåÑо¿ÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? µÚËľüÒ½´óѧһ¾Å¾ÅÈýÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æרҵ: ´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© 1. CD4 2. T cell receptor(TCR) xB{0lI
}J .f
5WaG
3. immunoglobulin superfamily (IgSF) v0!>":
f !t2a//
4. selectin bHcb+TR3
CBx 1.xL
5. anti-idiotypic antibody (¦ÁId) Be+'&+
$Ch!]lJA
6. major histocompatibility complex(MHC) E>Ukxi1
:$d3}TjsA+
7. immunotolerance ~k+"!'1
#M
*h)/d[A
8. biological reponse modifier(BRM) x.ZV<tD
i7
\{J gjd
9. immune reponse gene (Ir gene) 8r / ]Q
|RwpIe8~
10. reshaped antibody (or reconstituted antibody) yrO'15TB
3:jKuOX
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© Acr\2!))
F.c`0u;=
1. ¼òÊö°×ϸ°û½éËØ6(IL-6)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¡£ %j=dKd>
QQPbKok>
2. ϸ°û¶¾ÐÔTÁÜ°Íϸ°û(Tc»òCTL)Ó뿹ÌåÒÀÀµµÄϸ°û½éµ¼µÄϸ°û¶¾(ADCC)ɱÉË»úÀíÓкβ»Í¬? a`(6hL3IT
gT-'#K2qT
3. ¼òÊöµÚ¢ôÐÍ(³Ù·¢ÐÍ)±ä̬·´Ó¦µÄ·¢Éú»úÀí¡£ qdh;zAMx
qC?J
`
4. NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄ±íÃæ±ê¼Ç?NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄÉúÎïѧ»îÐÔ? iaXNf
])?
OQaM4 7"
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö) ¹©´«È¾²¡Ñ§×¨ÒµÊÔÌ⣺ bO1J#bcZ
a#FkoA~M
1. »úÌåÓÐÄÄЩÃâÒßϸ°ûºÍÃâÒß·Ö×Ó²ÎÓ뿹²¡¶¾¸ÐȾ?ËüÃÇÊÇÈçºÎ·¢»Ó²¡¶¾ÃâÒß×÷ÓõÄ? VaQ>g*(I
*MW)APw=
2. Ä¿Ç°µ¥¿Ë¡¿¹ÌåÔÚ²¡¶¾Ñ§ÖÐÓÐÄÄЩÖ÷ÒªÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ ,WA7Kp9
qu BTRW9
¹©Ïû»¯ÄÚ¿ÆרҵÊÔÌ⣺ 62rTGbDbx
)v;>6(
1. Ä¿Ç°ÌåÄÚºÍÌåÍâ¼ì²âÖ×Áö»¼ÕßÃâÒß¹¦Äܵķ½·¨Ö÷ÒªÓÐÄÄЩ?·Ö±ðÐðÊöÿÖÖ·½·¨µÄÔÀíºÍ½á¹û²â¶¨? q7mqzMDk
WK0?$[|=r
2. Ä¿Ç°µ¥¿Ë¡¿¹ÌåÔÚÖ×ÁöѧÖÐÓÐÄÄЩÖ÷ÒªµÄÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ f 7{E(,
>8Zz<S&z
µÚËľüÒ½´óѧһ¾Å¾ÅËÄÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æרҵ: Z"'rc.>a
1qbd6D|t
´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: OP]=MZP|
_IOeO
̉񧄤 \c/jp5=}
#9}KC 9f
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© >T;"bcb
-liVYI2s
1. CD8 YNc%[S[u^1
En
8-Hc#NC
2. T cell receptor ¦Á and ¦Â chain (TCR¦Á¦Â ) f}^}d"&
F
yxQxc5/X)
3. immunoglobulin fold(Ig fold) O^G/(
$5yS`IqS
4. cadherin (Ca-dependent cell adhesion moleculers) J)A1`(x&T
uljd)kLy4O
5. idiotype-anti-idiotypic antibody immune network theory flIdL,
VF!?B>
6. HLA class II antigen R!W!8rr3
`B) ~
7. complementarity-determining region (CDR) ':!w%& \
ye KzI~
8. perforin(or pore-forming protein ,PFP) f%ZqK_CW
3m#v|52oj
9. high affinity IL-2 receptor Zw| IY9D
d{hbgUSj
10. artificial active immunization -Vn9YeH+
);@Dr!H
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© jU)r~QhN
9@./=5N~3
1. ¼òÊö°×ϸ°û½éËØ2(IL-2)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¼°ÆäÔÚÁÙ´²ÖÎÁÆÖеÄÓ¦Óᣠ}+#-\a2
24Z7;'
2. Çë±È½ÏµÚ¢ñÐÍ(ËÙ·¢ÐÍ)³¬Ãô·´Ó¦ÓëµÚ¢ôÐÍ(³Ù·¢ÐÍ)³¬Ãô·´Ó¦µÄ·¢²¡Ìص㡣 a-4'jT:
m;WUp{'
3. ÊÔÊö·ÖÃÚÐÍIgA(secretory IgA)µÄ½á¹¹ÌصãºÍºÏ³É·ÖÃÚ¹ý³Ì¡£ -2o4v#d
Tc,Bv7:
4. ÊԱȽÏT¡¢BÁÜ°Íϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(Èç±íÃ濹ԡ¢±íÃæÊÜÌåµÈ)µÄÒìͬµã¡£ LVq3R 8A
699z@>$}
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö¡£Çë×¢Ò⣺ÿλ¿¼ÉúÖ»ÄÜ´Ó1¡¢2ÌâÖÐÑ¡Ò»Ìâ,3¡¢4ÌâÖÐÑ¡Ò»Ìâ,¹²´ðÁ½Ìâ,¶à´ðÕß²»¼Æ·Ö¡£) 1. Ä¿Ç°¼ì²âϸ°ûÒò×ÓÖ÷ÒªÓÐÉúÎïѧ»îÐÔ¼ì²â·¨ºÍÃâÒßѧ¼ì²â·¨,Çë¾ÙÀý·Ö±ðÐðÊöÁ½ÖÖ·½·¨µÄʵÑéÔÀí¡£ enj
Ti5X
\2U^y4K.
2. ΪÁ˱ÜÃâIgG¿¹ÌåFc¶Î·ÇÌØÒìÐÔ×÷ÓÃ,³£Ó¦ÓÃθµ°°×øˮ½âµÄF(ab¡¯)2¶Î,ÊÔÎÊÈçºÎÓ¦ÓÃSDS-PAGE·½·¨¶ÔF(ab¡¯)2½øÐмø¶¨? ^HLi1w|
yAU[A
3. ÊÔÊö¿¹Ö×Áö»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ :t?9$ dL
[^A.$,
4. ÊÔÊö¿¹²¡¶¾»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ ¡¡ 49bzHEqZ
S+R<wv,6
µÚËľüÒ½´óѧһ¾Å¾ÅÎåÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ =#&K\
jx!)N>
ѧ¿Æרҵ£ºÃâÒßѧ¡¢´«È¾²¡Ñ§¡¢Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿£ºÃâÒßѧ j.uN`cU!
=8X`QUmT
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© n }7DL8
bEV
9l
1. immunoglobulin gene rearrangement mAhtC*
e,={!P"f
2. the common chain of cytokine receptor (or a cytokine receptor subunit shared by some cytokine receptors) 2*vOo^f
Nb>|9nu
O
3. flow cytometry(FCM) -9~kp'_a
*!,+%0
4. carrier effect MX|CL{H
8X!U
tHml
5. positive selection of T lymphocytes in thymus p/:)Z_
},2-\-1
6. mouse TH1(Th1) and TH2(Th2) subsets &32qv`
V_
k~>9,=::d
7. perforin (pore-forming protein ,PFP) F@kOj*5,[
ge`)sB,
8. ADCC(antibody-dependent cell-mediated cytotoxicity) Fm3-Sn|Po
?g}n$%*5y!
9. SH-2(src-homology region 2) #StD]d
XLwbA4ORq
10. Ab2¦Â (internal image) kWF4k
;*:d)'A
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© /_rQ>PgSZW
UIv TC
S
1. ½üÄêÀ´ÔÚÈËÀà°×ϸ°û·Ö»¯¿¹Ô(CD)Ñо¿ÁìÓòÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? rwtSn?0z"
LXVm0IOFF
2. ²ÎÓë»î»¯Tϸ°ûÓë»î»¯Bϸ°ûÏ໥×÷ÓõķÖ×ÓÖ÷ÒªÓÐÄÄЩ?¼òÊöÆä½á¹¹ºÍ¹¦ÄÜ? =jkC]0qx
;8JJ#ED
3. ÊÔÊöHLAÔÚÁÙ´²ÉϵÄÖ÷ÒªÓ¦Óᣠ@?!/Pl49R
25l6@7q.
4. Àý¾ÙÈýÖÖ´ÓÈËÍâÖÜѪµ¥¸öºËϸ°û(PBMC)Öд¿»¯Tϸ°ûµÄ·½·¨,·Ö±ðÐðÊöÆäʵÑéÔÀíºÍÖ÷Òª²Ù×÷²½Öè¡£ X9/V;!
::dLOf8o
5. ÆÀ¼Ûºìϸ°ûÉú³ÉËØ(EPO)¡¢¸ÉÈÅËØ(IFN)ºÍ¼¯Âä´Ì¼¤Òò×Ó(CSF)ÔÚÁÙ´²Ä³Ð©¼²²¡µÄÓ¦Óᣠ?#qA>:2,
oZ& ns!#
Èý. Ñ¡ÔñÎÊ´ðÌâ(ÿÌâ10·Ö,¹²20·Ö¡£Çë°´±¨¿¼×¨Òµ´ðÌâ,Èç´ð·Ç±¾×¨ÒµÌâ»ò¶à´ðÌâ¾ùÊÓΪÎÞЧ¡£) //JF$o=)
D
req=w;E:
ÃâÒßѧרҵ£º 022YuqL<v
GuV-[
1. ÊÔÊöϸ°ûÒò×ÓÊÜÌåÖÐ,Ig³¬¼Ò×å¡¢ÔìѪÒò×ÓÊÜÌ峬¼Ò×å¡¢Éñ¾Éú³¤Òò×ÓÊÜÌ峬¼Ò×åÒÔ¼°Ç÷»¯Òò×ÓÊÜÌ峬¼Ò×åµÄÖ÷Òª½á¹¹Ìصã,ÿ¸ö³¬¼Ò×åÀý¾Ù³ö2¸ö³ÉÔ±¡£ %\}|&